SCHEMBL7107059

SCHEMBL7107059

C=CC(c1[c]cccc1)c1ccccc1O

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10855944 0.80 GABRA1 (0.50) GABRA1GABRB2TSHR
SCHEMBL461883 0.78 GABRA1 (0.48) GABRA1GABRB2TSHR
SCHEMBL3011286 0.75 KDM4E (0.41)
SCHEMBL10762626 0.73 GABRA1 (0.43) GABRA1GABRB2TSHR
SCHEMBL2049372 0.71 ALDH1A1 (0.31) TSHR
SCHEMBL11770504 0.69 SLC6A2 (0.37) TSHR
SCHEMBL8761478 0.68 CA1 (0.52) GABRA1GABRB2TSHR
SCHEMBL7141221 0.68 GABRA1 (0.50) GABRA1GABRB2TSHR
SCHEMBL11116133 0.67
SCHEMBL5424032 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed